Neng Nana
Taiwan has officially transitioned into a "super-aged society," a demographic milestone where more than 20% of the total population is aged 65 or older. This shift has placed unprecedented pressure on the nation’s healthcare infrastructure, characterized by a rising prevalence of chronic diseases, age-related disabilities, infectious disease threats, and cancer. While the Republic of China (Taiwan) has historically been praised for its National Health Insurance (NHI) system and high level of medical accessibility, experts and policymakers now warn that the current framework is overly weighted toward "downstream" care—treating illnesses after they become severe—rather than "upstream" prevention. To address these systemic vulnerabilities, the Lai Ching-te administration has introduced the "Healthy Taiwan" vision, prompting a series of comprehensive recommendations aimed at strengthening healthcare resilience through precision care, digital innovation, and integrated governance.
The Demographic Shift and the Healthy Taiwan Vision
The transition to a super-aged society is not merely a statistical change but a fundamental shift in the socio-economic fabric of Taiwan. According to data from the National Development Council, Taiwan is aging at one of the fastest rates in the world, with the elderly population expected to continue growing significantly over the next two decades. This demographic reality necessitates a pivot from traditional reactive medicine to a proactive, outcome-oriented healthcare model.
The administration’s "Healthy Taiwan" initiative seeks to reduce the number of "unhealthy years" lived by citizens—currently averaging eight years—and to lower cancer mortality by one-third. However, achieving these goals requires a departure from fragmented care. Currently, healthcare delivery is often siloed between primary care providers, regional hospitals, and specialized medical centers. The Committee on healthcare policy recommends a more integrated approach that connects chronic disease management, healthy aging, immunization, and smart healthcare through cross-sector coordination and public-private collaboration.
Strengthening Chronic Disease Governance Through Precision Care
Chronic conditions, particularly diabetes and chronic kidney disease (CKD), are the primary drivers of NHI expenditure. Data from the National Health Insurance Administration (NHIA) reveals that these two conditions alone account for more than NT$100 billion in annual costs. To mitigate this, the government has introduced the "888 Plan," which targets 80% screening rates, 80% treatment rates, and 80% control rates for chronic diseases.
The Committee suggests that the next phase of the 888 Plan must involve a "precision care" model. This involves risk stratification, where patients are categorized based on their glycemic control, body mass index (BMI), and comorbidities to receive personalized intervention. For instance, high-risk patients with early signs of renal impairment should be fast-tracked into specialized care networks to delay the progression to end-stage renal disease, which necessitates costly dialysis.
Furthermore, the Committee identifies a gap in the current "Pay-for-Performance" (P4P) models. While these models have improved quality, the reimbursement points for early-stage CKD are significantly lower than those for metabolic syndrome, reducing the incentive for medical institutions to enroll patients in early intervention programs. A proposed National Chronic Disease Cross-Sector Alliance would aim to align these incentives, ensuring that primary care and medical centers work in tandem rather than in competition.
Addressing Obesity as an Upstream Priority
In a significant policy shift, the Executive Yuan recently announced that "Healthy Taiwan" will prioritize obesity and fatty liver care. Obesity is increasingly recognized as a critical "upstream" driver of diabetes, cardiovascular disease, and cancer. The Committee recommends following international precedents, such as South Korea’s NHI model, by integrating BMI monitoring into standardized health checks.
By prioritizing overweight and obese populations—including children and adolescents—for longitudinal management, the government aims to prevent the onset of chronic diseases decades before they manifest. This strategy includes both lifestyle interventions and pharmacological treatments, supported by family-centered guidelines to ensure that healthy habits are reinforced within the home.
Early Intervention for Aging-Related Conditions and Dementia
As the population ages, the burden of functional decline and dementia grows. Currently, 30% of Taiwan’s population aged 65 and above is at risk of frailty or disability. The Committee argues that a policy focused solely on expanding long-term care capacity is unsustainable. Instead, the focus must shift toward "pre-disability" intervention.
Dementia management is a primary concern. Current frameworks often focus on moderate to severe cases, but the emergence of disease-modifying therapies for Alzheimer’s disease and advances in biomarker-based diagnostics (such as PET scans and blood-based screening) offer a window for earlier intervention. Shifting from a disability-focused model to a "brain-health management" approach could significantly delay the onset of severe cognitive decline, thereby reducing the long-term caregiving burden on families and the state.
Similarly, for stroke and neurodegenerative diseases, the Committee recommends strengthening the integration between post-acute care and the "Long-Term Care 3.0" program. By utilizing dedicated care managers to oversee rehabilitation adherence and risk-factor control, the system can preserve functional independence for longer periods.
Immunization: A Pillar of Healthcare Resilience
Vaccination is among the most cost-effective public health interventions, yet adult and elderly coverage in Taiwan remains suboptimal. Influenza vaccination among those aged 65+ stands at approximately 50%, while pneumococcal completion rates are below 40%. In a super-aged society, infectious diseases can quickly overwhelm hospital capacity, as seen during the COVID-19 pandemic.
To improve uptake, the Committee recommends embedding vaccination into routine chronic disease management. For example, the "Family Physician Program" could use digital reminder systems to ensure that patients with diabetes or heart disease—who are at higher risk of complications—receive their pneumonia and COVID-19 boosters.
On the regulatory side, the Committee suggests a shift toward a risk-based, tiered testing approach for vaccine lot release. Instead of full-panel testing for every single batch, which can cause delays, a simplified testing process for subsequent batches (after the first three) could improve efficiency. Recognition of testing standards from the EU or "A10" countries would also expedite access to innovative vaccines.
Scaling the Digital Health Ecosystem: The "Health Coin"
Digital innovation is viewed as a force multiplier for healthcare efficiency. The "Health Coin" initiative is a central part of this strategy. This program offers digital incentives to citizens who engage in preventive health activities, such as attending screenings or reaching step-count goals.
The Committee urges the government to expand the Health Coin ecosystem by integrating data from wearable devices and home-based monitoring tools into the "My Health Bank" platform. For patients undergoing home-based care, such as home dialysis, the Health Coin program could incentivize self-management, thereby reducing the need for hospital visits.
To address privacy concerns, the Committee proposes a "data-enabled incentive framework." This would allow the private sector (fitness centers, nutritionists, etc.) to offer rewards based on government-verified "health achievement signals" without actually accessing the individual’s private medical records. This public-private collaboration is essential for creating a holistic wellness culture.
Reforming Cancer Control and the Cancer Drugs Fund
Cancer has been the leading cause of death in Taiwan for over 40 years. While the government has expanded screening for HPV, gastric cancer, and lung cancer, participation remains uneven. Screening for breast and colorectal cancer remains below 40%, leading to many cases being detected at advanced stages.
The Committee recommends adopting risk-based screening strategies and addressing urban-rural disparities through mobile health services. Furthermore, to improve survival rates, Taiwan must optimize reimbursement for next-generation sequencing (NGS) to align with international precision medicine standards.
A critical component of this reform is the "Cancer Drugs Fund." The Committee recommends scaling this fund to NT$10 billion to ensure that patients have access to innovative, life-saving therapies that might otherwise be delayed by NHI budget constraints. Establishing a clear legal framework and a predictable transition path for drugs moving from the fund to the permanent NHI reimbursement system is vital for maintaining continuity of care.
Analysis of Implications: A Sustainable Path Forward
The transition to a super-aged society presents an existential challenge to Taiwan’s National Health Insurance system. The recommendations provided by the Committee suggest that the "Healthy Taiwan" vision is not just a health policy, but an economic necessity. By shifting the focus upstream, the government can reduce the "unhealthy life expectancy" of its citizens, which currently stands at nearly 10% of the average lifespan.
Reducing this gap by even two percentage points would result in billions of NT dollars in savings and significantly improve the quality of life for millions. However, the success of these reforms depends on "cross-sectoral synergy." The integration of digital tools, the alignment of financial incentives, and the expansion of public-private partnerships represent a fundamental restructuring of how Taiwan perceives health—moving from a system that manages sickness to one that actively cultivates longevity and resilience. As 2025 approaches, the implementation of these "upstream" strategies will determine whether Taiwan’s healthcare system can survive the silver tsunami or if it will be overwhelmed by the weight of its own success in extending human life.
Nila Kartika Wati
Pevita Pearce
